Fewer patients in the acalabrutinib group experienced treatment-emergent cardiovascular medical events after BTKi initiation compared with those in the zanubrutinib group.
Americans are not eating well, Stanford Medicine’s Christopher Gardner says, but he is hopeful that encouraging patterns of eating — such as the Mediterranean diet…
Integrating pretreatment frailty assessments into clinical workflows may help oncologists better identify older adults with NSCLC at risk for poor outcomes.
What is a coronary artery calcium scan (CACS)? It is a simple CT of the heart performed without injection of any contrast dyes that permits…
Advances in obesity medicine are reshaping the science and practice of cardiology. JACC’s new comprehensive hub highlights the latest research, commentary, and multimedia, including a…
JACC Associate Editor Neha J. Pagidipati, MD, FACC, speaks with author Christopher M. Kramer, MD, FACC about this substudy of the SUMMIT trial published in…
Explore the key findings and clinical implications of the SUMMIT CMR Substudy in this engaging webinar. Hear from study authors Christopher M. Kramer, MD, FA…
AbstractBackgroundObesity is a known risk factor for heart failure with preserved ejection fraction (HFpEF) and is considered a distinct phenotype with more concentric remodeling. Epicardial…
Sanita Burgic, MSN, APRN, AGNP-C, of the Siteman Cancer Center at the Washington University School of Medicine in St. Louis, speaks about her JADPRO Live…
AbstractThis state-of-the-art review examines disparities in the diagnosis, management, and outcomes of cardiac arrhythmias globally. These arrhythmias include atrial fibrillation, ventricular tach…
A study examined whether the use of potassium binder sodium zirconium cyclosilicate (SZC) with dialysate potassium could reduce postdialysis heart arrhythmias.
